Table 1.
Demographic characteristics, clinical, and experimental composite scores for participantsa,b,c
| bvFTD | AD | Controls | Group effect | AD versus bvFTD | |
|---|---|---|---|---|---|
| N | 19 | 18 | 19 | ||
| Sex (m:f) | 11:8 | 11:7 | 8:11 | n/s | n/s |
| Age (years) | 63.6 (7.9) | 65.8 (6.8) | 68.1 (5.3) | n/s | n/s |
| Education (years) | 12.6 (3.3) | 12.1 (3.6) | 13.1 (2.4) | n/s | n/s |
| Disease duration (months) | 47.1 (27.2) | 34.1 (13.6) | n/a | n/s | n/s |
| ACE‐R total (100) | 77.5 (12.0) | 77.2 (12.5) | 94.8 (3.5) | b | n/s |
| Trails (B‐A in s) | 124.8 (100.1) | 127.2 (72.8) | 51.9 (29.6) | a | n/s |
| Letter fluency | 23.9 (12.4) | 30.9 (12.0) | 45.9 (13.7) | b | n/s |
| Hayling scaled score | 2.6 (2.0) | 3.8 (2.0) | 6.2 (0.5) | b | n/s |
| CBI Total (100) | 44.4 (27.9) | 57.5 (31.8) | n/a | n/s | n/s |
| Recall composite score (100) | 24.5 (16.8) | 22.3 (19.1) | 63.9 (13.4) | b | n/s |
| Recognition composite score (100) | 74.5 (17.1) | 70.9 (16.9) | 89.6 (9.0) | b | n/s |
Standard deviations in brackets, maximum score for tests shown in brackets.
bvFTD = behavioral variant frontotemporal dementia; AD = Alzheimer's disease; ACE‐R = Addenbrooke's Cognitive Examination Revised; CBI = Cambridge Behavioral Inventory.
Trail Making test data available for 13 bvFTD and 12 AD cases. CBI information available for 17 AD and 15 bvFTD patients. Hayling data available for 17 bvFTD cases.
a
P < 0.05;
b
P < 0.0001; n/s = not significant; n/a = not applicable.